BACKGROUND: Studies of viral load-associated persistence of human papillomavirus (HPV) infection are rare, with inconsistent results reported. METHODS: The study subjects were 741 and 289 women who were positive for HPV type 16 (HPV-16) and HPV type 18 (HPV-18), respectively, at the time of enrollment into in the ASCUS-LSIL (Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion) Triage Study and who returned 1 or more times for HPV testing during a biannual 2-year follow-up. The numbers of HPV-16 and HPV-18 copies per nanogram of cellular DNA at baseline were measured by use of real-time polymerase chain reaction. RESULTS: Women with, compared with women without, persistent infection at month 6 of follow-up had a higher viral load at enrollment (P< .001, for HPV-16; P=.01, for HPV-18). The association of each 1-log(10) increase in viral load with persistence of HPV-16 or HPV-18 during the first 6 months of the study was statistically significant among women with multiple HPV types at enrollment (for HPV-16: odds ratio [OR], 1.53 [95% confidence interval {CI}, 1.29-1.82]; for HPV-18: OR, 1.35 [95% CI, 1.09-1.68]) but not among women with monotype infections (in tests assessing the interaction between viral load and coinfection, P=.002 for HPV-16 and P=.34 for HPV-18). Among women who continued to have positive results at month 6, 12, or 18, persistence of infection for another 6 months was unassociated with the viral load at baseline. CONCLUSION: Prevalent infection with a higher viral load of HPV-16 or HPV-18 was associated with short- but not long-term persistence.
BACKGROUND: Studies of viral load-associated persistence of humanpapillomavirus (HPV) infection are rare, with inconsistent results reported. METHODS: The study subjects were 741 and 289 women who were positive for HPV type 16 (HPV-16) and HPV type 18 (HPV-18), respectively, at the time of enrollment into in the ASCUS-LSIL (Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion) Triage Study and who returned 1 or more times for HPV testing during a biannual 2-year follow-up. The numbers of HPV-16 and HPV-18 copies per nanogram of cellular DNA at baseline were measured by use of real-time polymerase chain reaction. RESULTS:Women with, compared with women without, persistent infection at month 6 of follow-up had a higher viral load at enrollment (P< .001, for HPV-16; P=.01, for HPV-18). The association of each 1-log(10) increase in viral load with persistence of HPV-16 or HPV-18 during the first 6 months of the study was statistically significant among women with multiple HPV types at enrollment (for HPV-16: odds ratio [OR], 1.53 [95% confidence interval {CI}, 1.29-1.82]; for HPV-18: OR, 1.35 [95% CI, 1.09-1.68]) but not among women with monotype infections (in tests assessing the interaction between viral load and coinfection, P=.002 for HPV-16 and P=.34 for HPV-18). Among women who continued to have positive results at month 6, 12, or 18, persistence of infection for another 6 months was unassociated with the viral load at baseline. CONCLUSION: Prevalent infection with a higher viral load of HPV-16 or HPV-18 was associated with short- but not long-term persistence.
Authors: Ligia A Pinto; Raphael Viscidi; Clayton D Harro; Troy J Kemp; Alfonso J García-Piñeres; Matthew Trivett; Franklin Demuth; Douglas R Lowy; John T Schiller; Jay A Berzofsky; Allan Hildesheim Journal: Virology Date: 2006-07-24 Impact factor: 3.616
Authors: Satu-Maria A Kulmala; Irena P Shabalova; Nikolay Petrovitchev; Kari J Syrjänen; Ulf B Gyllensten; Bo C Johansson; Stina M Syrjänen Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-01 Impact factor: 4.254
Authors: Melinda Butsch Kovacic; Philip E Castle; Rolando Herrero; Mark Schiffman; Mark E Sherman; Sholom Wacholder; Ana C Rodriguez; Martha L Hutchinson; M Concepción Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Robert D Burk Journal: Cancer Res Date: 2006-10-15 Impact factor: 12.701
Authors: K L Liaw; A Hildesheim; R D Burk; P Gravitt; S Wacholder; M M Manos; D R Scott; M E Sherman; R J Kurman; A G Glass; S M Anderson; M Schiffman Journal: J Infect Dis Date: 2000-11-16 Impact factor: 5.226
Authors: Long Fu Xi; Nancy B Kiviat; Denise A Galloway; Xiao-Hua Zhou; Jesse Ho; Laura A Koutsky Journal: J Infect Dis Date: 2008-08-01 Impact factor: 5.226
Authors: Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Philip E Castle; Diane Solomon; Robert Burk Journal: J Natl Cancer Inst Date: 2008-03-25 Impact factor: 13.506
Authors: Helen Trottier; Salaheddin Mahmud; José Carlos M Prado; Joao S Sobrinho; Maria C Costa; Thomas E Rohan; Luisa L Villa; Eduardo L Franco Journal: J Infect Dis Date: 2008-05-15 Impact factor: 5.226
Authors: Ali Rowhani-Rahbar; Stephen E Hawes; Papa Salif Sow; Papa Toure; Qinghua Feng; Ahmadou Dem; Birama Dembele; Cathy W Critchlow; Ibraham N'Doye; Nancy B Kiviat Journal: J Infect Dis Date: 2007-08-07 Impact factor: 5.226
Authors: Brian Lowe; Lori Kobayashi; Attila Lorincz; Rick Mallonee; Dominic O'Neil; Ha Thai; Irina Nazarenko Journal: J Mol Diagn Date: 2010-09-16 Impact factor: 5.568
Authors: Virginia Senkomago; Danielle M Backes; Michael G Hudgens; Charles Poole; Kawango Agot; Stephen Moses; Peter J F Snijders; Chris J L M Meijer; Albertus T Hesselink; Nicolas F Schlecht; Robert C Bailey; Jennifer S Smith Journal: J Infect Dis Date: 2014-09-26 Impact factor: 5.226
Authors: Zoe R Edelstein; Joseph J Carter; Ruchi Garg; Rachel L Winer; Qinghua Feng; Denise A Galloway; Laura A Koutsky Journal: J Infect Dis Date: 2011-07-15 Impact factor: 5.226
Authors: Xia Liu; Mark Schiffman; Ayaka Hulbert; Zhonghu He; Zhenping Shen; Laura A Koutsky; Long Fu Xi Journal: J Clin Microbiol Date: 2015-08-19 Impact factor: 5.948
Authors: Long Fu Xi; James P Hughes; Philip E Castle; Zoe R Edelstein; Chunhui Wang; Denise A Galloway; Laura A Koutsky; Nancy B Kiviat; Mark Schiffman Journal: J Infect Dis Date: 2011-03-16 Impact factor: 5.226
Authors: Mary K Grabowski; Ronald H Gray; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Steven J Reynolds; Maria J Wawer; Stephen Watya; Thomas C Quinn; Aaron A R Tobian Journal: Sex Transm Infect Date: 2014-01-30 Impact factor: 3.519
Authors: Mitzie-Ann Davis; Ronald H Gray; Mary K Grabowski; David Serwadda; Godfrey Kigozi; Patti E Gravitt; Fred Nalugoda; Stephen Watya; Maria J Wawer; Thomas C Quinn; Aaron A R Tobian Journal: Int J Cancer Date: 2013-03-07 Impact factor: 7.396
Authors: Anil K Chaturvedi; Barry I Graubard; Robert K L Pickard; Weihong Xiao; Maura L Gillison Journal: J Infect Dis Date: 2014-03-12 Impact factor: 5.226
Authors: Rachel L Winer; Long Fu Xi; Zhenping Shen; Joshua E Stern; Laura Newman; Qinghua Feng; James P Hughes; Laura A Koutsky Journal: Int J Cancer Date: 2013-10-18 Impact factor: 7.396